Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
NN1679-8505
NovoThirteen
Healthy participants and participants with type 2 diabetes
1 trial -
NN6582-4838
NovoThirteen
Healthy Volunteers
1 trial -
NN6706-8230
NovoThirteen
Healthy volunteers, treatment for heart failure
1 trial -
NN9490-8151
NovoThirteen
Participants with obesity, but otherwise healthy
1 trial -
NN9541-4922
NovoThirteen
Healthy postmenopausal females (Type 2 Diabetes)
1 trial -
NN9733-8133
NovoThirteen
Healthy Participants and Participants with type 2 diabetes
1 trial -
NNC0480-0389
Novo Nordisk A/S
Healthy Volunteers Type 2 Diabetes
1 trial -
NPC-22
Belpharma s.a.
Healthy Adult Subjects
1 trial -
NRS-033
BRIGHT MINDS BIOSCIENCES INC.
Healthy Volunteers
1 trial -
NX-5948
Nurix Therapeutics
Healthy Volunteer
2 trials -
NX210c
BRIGHT MINDS BIOSCIENCES INC.
Healthy Elderly
1 trial -
Neratinib
PUMA BIOTECHNOLOGY, INC.
Healthy Subjects
3 trials -
Nifedipine 60 MG Extended Release Oral Tablet
BRIGHT MINDS BIOSCIENCES INC.
Healthy Volunteers
1 trial -
Norethindrone/Ethinyl Estradiol
Teva Pharma GmbH
Healthy
1 trial -
Norovirus
United Therapeutics Europe Ltd
Healthy Adults
1 trial -
ORG-129
Agomab Therapeutics NV
Healthy Volunteers
1 trial -
ORIC-101
Topiloric/Uriadec
Healthy Volunteers
2 trials -
ORIC-114
Topiloric/Uriadec
Food Effect in Healthy Participants
1 trial -
ORKA-001
Oruka Therapeutics
Healthy Volunteers
1 trial -
ORKA-002
Oruka Therapeutics
Healthy Volunteers
1 trial -
ORX489 Tablets
Centessa Pharmaceuticals plc
Healthy Adult Male and Female Volunteers
1 trial -
Olezarsen
IONIS PHARMACEUTICALS INC
Healthy Participants
1 trial -
Olinciguat
Cyclerion Therapeutics
Healthy
1 trial -
Olomorasib
Eli Lilly and Company
Healthy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.